EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancements in the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Comprehensive Review

Randeep Gill, Arsalan Siddiqui, Brianna Yee iD, Michael V DiCaro iD, Nazanin Houshmand, Tahir Tak

Journal of Cardiovascular Development and Disease · 18.09.2024 · 11 (9) · 290

DOI: 10.3390/jcdd11090290 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 18.09.2024. Verfasst von Randeep Gill und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV 89102, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kirk Kerkorian School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic cardiomyopathy (HCM) is characterized by excessive growth of myocardial tissue, most commonly due to genetic mutations in sarcomere proteins. This can lead to complications such as heart failure, mitral regurgitation, syncope, arrhythmias, sudden cardiac death, and myocardial ischemia. While we have come a long way in our understanding of the pathophysiology, genetics, and epidemiology of HCM, the past 10 years have seen significant advancements in diagnosis and treatment. As the body of evidence on hypertrophic cardiomyopathy continues to grow, a comprehensive review of the current literature is an invaluable resource in organizing this knowledge. By doing so, the vast progress that has been made thus far will be widely available to all experts in the field. This review provides a comprehensive analysis of the scientific literature, exploring both well-established and cutting-edge diagnostic and therapeutic options. It also presents a unique perspective by incorporating topics such as exercise testing, genetic testing, radiofrequency ablation, risk stratification, and symptomatic management in non-obstructive HCM. Lastly, this review highlights areas where current and future research is at the forefront of innovation in hypertrophic cardiomyopathy.

Schlagwörter

Stichwörter der Autor:innen

alcohol septal ablationheart failurehypertrophic obstructive cardiomyopathymavacamtenmitral valve regurgitationseptal myectomysystolic anterior motion

Autor:innen und Institutionen

  • Department of Internal Medicine, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV 89102, USA.
  • VA Southern Nevada Healthcare System, 6900 N. Pecos Road, North Las Vegas, NV 89086, USA.

ORCID-Profile: Brianna Yee, Michael V DiCaro

Förderung

  • Kirk Kerkorian School of Medicine

Zitieren

APA

Gill, R., Siddiqui, A., Yee, B., DiCaro, M. V., Houshmand, N., & Tak, T. (2024). Advancements in the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Comprehensive Review. Journal of Cardiovascular Development and Disease, 11(9), 290. https://doi.org/10.3390/jcdd11090290

Vancouver

Gill R, Siddiqui A, Yee B, DiCaro MV, Houshmand N, Tak T. Advancements in the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Comprehensive Review. Journal of Cardiovascular Development and Disease. 2024;11(9):290. doi:10.3390/jcdd11090290

BibTeX
@article{Gill2024,
  author = {Gill, Randeep and Siddiqui, Arsalan and Yee, Brianna and DiCaro, Michael V and Houshmand, Nazanin and Tak, Tahir},
  title = {Advancements in the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Comprehensive Review},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2024},
  volume = {11},
  number = {9},
  pages = {290},
  doi = {10.3390/jcdd11090290}
}
Kostenlos starten →